Global Diabetes Devices Market Overview And Scope:
Global Diabetes Devices Market Size was estimated at USD 22520.53 million in 2022 and is projected to reach USD 32607.84 million by 2028, exhibiting a CAGR of 6.36% during the forecast period.
The Global Diabetes Devices Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Diabetes Devices utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Medtronic, Sanofi, Bayer, Becton, Dickinson and Company, Novo Nordisk, Abbott Laboratories, Roche, Lifescan, B. Braun, Dexcom, Ypsomed Holdings
Global Diabetes Devices Market Segmentation
By Type, Diabetes Devices market has been segmented into:Blood Glucose Monitoring (BGM) Devices
Insulin Delivery Devices
By Application, Diabetes Devices market has been segmented into:
Hospital
Personal Use
Clinic
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Diabetes Devices market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Diabetes Devices market.
Top Key Players Covered in Diabetes Devices market are:
Medtronic
Sanofi
Bayer
Becton
Dickinson and Company
Novo Nordisk
Abbott Laboratories
Roche
Lifescan
B. Braun
Dexcom
Ypsomed Holdings
Objective to buy this Report:
1. Diabetes Devices analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Diabetes Devices market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Diabetes Devices Market by Type
5.1 Diabetes Devices Market Overview Snapshot and Growth Engine
5.2 Diabetes Devices Market Overview
5.3 Blood Glucose Monitoring (BGM) Devices
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Blood Glucose Monitoring (BGM) Devices: Geographic Segmentation
5.4 Insulin Delivery Devices
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Insulin Delivery Devices: Geographic Segmentation
Chapter 6: Diabetes Devices Market by Application
6.1 Diabetes Devices Market Overview Snapshot and Growth Engine
6.2 Diabetes Devices Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Personal Use
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Personal Use: Geographic Segmentation
6.5 Clinic
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinic: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Diabetes Devices Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Diabetes Devices Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Diabetes Devices Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MEDTRONIC
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 SANOFI
7.4 BAYER
7.5 BECTON
7.6 DICKINSON AND COMPANY
7.7 NOVO NORDISK
7.8 ABBOTT LABORATORIES
7.9 ROCHE
7.10 LIFESCAN
7.11 B. BRAUN
7.12 DEXCOM
7.13 YPSOMED HOLDINGS
Chapter 8: Global Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Blood Glucose Monitoring (BGM) Devices
8.2.2 Insulin Delivery Devices
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Personal Use
8.3.3 Clinic
8.3.4 Others
Chapter 9: North America Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Blood Glucose Monitoring (BGM) Devices
9.4.2 Insulin Delivery Devices
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Personal Use
9.5.3 Clinic
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Blood Glucose Monitoring (BGM) Devices
10.4.2 Insulin Delivery Devices
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Personal Use
10.5.3 Clinic
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Blood Glucose Monitoring (BGM) Devices
11.4.2 Insulin Delivery Devices
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Personal Use
11.5.3 Clinic
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Blood Glucose Monitoring (BGM) Devices
12.4.2 Insulin Delivery Devices
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Personal Use
12.5.3 Clinic
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Blood Glucose Monitoring (BGM) Devices
13.4.2 Insulin Delivery Devices
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Personal Use
13.5.3 Clinic
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Diabetes Devices Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Blood Glucose Monitoring (BGM) Devices
14.4.2 Insulin Delivery Devices
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Personal Use
14.5.3 Clinic
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Diabetes Devices Scope:
|
Report Data
|
Diabetes Devices Market
|
|
Diabetes Devices Market Size in 2022
|
USD 22520.53 million
|
|
Diabetes Devices CAGR 2023 - 2030
|
6.36%
|
|
Diabetes Devices Base Year
|
2022
|
|
Diabetes Devices Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Medtronic, Sanofi, Bayer, Becton, Dickinson and Company, Novo Nordisk, Abbott Laboratories, Roche, Lifescan, B. Braun, Dexcom, Ypsomed Holdings.
|
|
Key Segments
|
By Type
Blood Glucose Monitoring (BGM) Devices
Insulin Delivery Devices
By Applications
Hospital
Personal Use
Clinic
Others
|
